SCHEMBL24449220

SCHEMBL24449220

Cc1c(C(C)(C)C)c(F)cc2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.39
▸ CYP2A6 P11509 3/20 0.39
▸ TSHR P16473 2/20 0.39
▸ HPRT1 P00492 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ HIF1A Q16665 2/20 0.34
▸ CYP1B1 Q16678 1/20 0.34
▸ HPGD P15428 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ TRPA1 O75762 1/20 0.33
▸ CYP3A4 P08684 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ NCEH1 Q6PIU2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16219581 0.84 CYP1A2 (0.35) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL24446570 0.78 CYP2A6 (0.46) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL26058913 0.76 HPRT1 (0.35) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL14902935 0.76 CYP2A6 (0.45) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL24631891 0.74 CYP1A2 (0.39) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL16219575 0.74 ALDH1A1 (0.46) HPRT1ALDH1A1HPGDKDM4EMAPK1
SCHEMBL24859351 0.73 ALDH1A1 (0.44) CYP1A2CYP2A6TSHRALDH1A1HSD17B10
SCHEMBL24175934 0.73 CYP2A6 (0.47) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL12017092 0.72 CYP2A6 (0.43) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL26051993 0.71 CYP1A2 (0.37) CYP1A2CYP2A6TSHRALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230118106-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-04-20 — — US disclosed
US-20230008665-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-01-12 — — US disclosed
US-20220162243-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162243-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, LOXL1 CYP1A2 145/4885CYP2A6 1353/4885TSHR 3371/4885
US-20230008665-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ICOSLG, OCIAD2, OCIAD1 CYP1A2 1238/4885CYP2A6 4001/4885TSHR 1699/4885
US-20230118106-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OPRD1, OCIAD2, OCIAD1 CYP1A2 1195/4885CYP2A6 1455/4885TSHR 1517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback